Laboratory researchers evaluating growth hormone secretagogue pathways require high-purity, structurally verified research compounds. PX1 Research supplies USA-manufactured Tesamorelin and Ipamorelin manufactured in GMP-compliant facilities, verified via RP-HPLC and mass spectrometry, and supplied with lot-specific analytical documentation. All products are strictly intended for in vitro and laboratory research applications.
Laboratory researchers evaluating growth hormone secretagogue pathways require high-purity, structurally verified research compounds. PX1 Research supplies USA-manufactured Tesamorelin and Ipamorelin manufactured in GMP-compliant facilities, verified via RP-HPLC and mass spectrometry, and supplied with lot-specific analytical documentation. All products are strictly intended for in vitro and laboratory research applications.
To buy Tesamorelin and Ipamorelin for laboratory research, investigators must source from specialized suppliers providing analytical verification of sequence identity and peptide purity. PX1 Research supplies research-grade Tesamorelin and Ipamorelin manufactured in USA-based GMP-compliant facilities, accompanied by lot-specific third-party COAs including RP-HPLC purity, mass spectrometry, and endotoxin testing.
Both compounds represent distinct structural classes within the growth hormone secretagogue (GHS) family. When evaluated in experimental models, these peptides allow researchers to examine dual-pathway activation of somatotrope receptors without disrupting downstream endocrine baselines. Ordering through dedicated research platforms guarantees lot traceability, reliable lyophilization, and cold-chain integrity required for reproducible quantitative assays.
Tesamorelin is a trans-3-hexenoyl stabilized synthetic analog of human growth hormone-releasing hormone (GHRH, 1-44). The addition of the hexenoyl moiety to the N-terminal arginine residual imparts resistance against dipeptidyl peptidase-4 (DPP-IV) enzymatic cleavage. In cell culture models and isolated pituitary tissue, Tesamorelin binds directly to the GHRH receptor (GHRHR), initiating a G-protein-coupled signaling cascade that activates adenylate cyclase. This activation raises intracellular cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA), driving transcriptions of endogenous growth hormone (GH) in anterior pituitary somatotropes.
Conversely, Ipamorelin operates through an entirely distinct molecular target. Classified as a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), Ipamorelin acts as a selective agonist at the growth hormone secretagogue receptor 1a (GHSR-1a), commonly recognized as the ghrelin receptor. Activation of GHSR-1a triggers intracellular calcium mobilization via the phospholipase C (PLC) and inositol trisphosphate (IP3) pathways. Researchers interested in broader receptor cross-talk often consult our research library to examine how dual receptor signaling operates within various cellular systems.
Because these two compounds bind to distinct receptor sites—GHRHR and GHSR-1a—preclinical research frequently investigates their simultaneous or sequential application. Dual stimulation of somatotropes via both PKA and IP3 signaling pathways is studied to characterize potentially synergistic GH release without exhausting cellular receptor populations.
In animal models, growth hormone release under natural conditions occurs in discrete, high-amplitude pulses rather than continuous tonic secretion. Preclinical studies suggest that synthetic secretagogues which preserve this natural pulsatility maintain tissue sensitivity and prevent down-regulation of endogenous receptors. Tesamorelin and Ipamorelin have both demonstrated an ability to induce physiological-like pulsatile spikes in growth hormone levels in rodent and non-human primate research.
A critical parameter in evaluating growth hormone secretagogues is receptor selectivity. Traditional secretagogues, particularly earlier-generation hexapeptides, frequently activated secondary neuroendocrine pathways, driving unwanted elevations in adrenocorticotropic hormone (ACTH), cortisol, and prolactin. In vitro data indicate that Ipamorelin exhibits exceptional receptor specificity for GHSR-1a, eliciting somatotrope release while demonstrating negligible affinity for receptors governing ACTH or prolactin expression.
Similarly, research models evaluating Tesamorelin mechanisms show selective GHRHR engagement. This structural precision allows investigators to isolate growth hormone axis responses from confounding stress-hormone cascades, ensuring clear baseline readings during metabolic, body composition, and tissue preservation studies.
When designing preclinical trials, researchers frequently compare Tesamorelin and Ipamorelin against other established compounds within the growth hormone secretagogues category. Key differences exist across terminal half-life, receptor affinity, and secondary hormonal activity, as summarized below:
Compared to CJC-1295, which also targets the GHRH receptor, Tesamorelin possesses a unique hexenoyl modification that specifically preserves natural episodic pulsatility while resisting cleavage. When contrasted with GHRP-6, Ipamorelin provides equivalent or superior GH secretagogue efficacy without inducing non-specific cortisol, prolactin, or appetite-stimulating signaling. Evaluating these distinct parameters helps research facilities choose appropriate molecular tools for specific targeted assays.
In analytical chemistry and cell biology, peptide purity directly dictates test validity. Impurities such as truncated sequences, counter-ion residues, or deletion peptides can obscure biological signals, cause cytotoxic reactions in cell cultures, or disrupt binding kinetic assays. To guarantee experimental repeatability, PX1 Research Subjects every batch of Tesamorelin and Ipamorelin to rigorous analytical testing.
Purity is quantitatively established using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). PX1 Research mandates a minimum purity threshold of 99% for all research peptides. Mass spectrometry (MS) analysis is performed concurrently to confirm exact molecular weight and amino acid sequence fidelity, ruling out structural isomers or degradation fragments.
Furthermore, bacterial endotoxins present a severe hazard to in vitro cell culture models and preclinical animal protocols. PX1 Research conducts LAL (Limulus Amebocyte Lysate) assay testing on every production lot, enforcing an endotoxin limit of <0.5 EU/mg. This guarantees that research compounds will not induce non-specific inflammatory responses or septic pathways during sensitive cellular assays.
Both Tesamorelin and Ipamorelin are supplied as sterile, lyophilized (freeze-dried) cakes or powders in sealed glass vials under inert gas. Lyophilization preserves the peptide matrix against thermal hydrolysis and oxidation during transport. Upon delivery, un-reconstituted vials should be stored at -20°C in a dry, dark freezer environment to preserve structural stability.
Reconstitution must be executed under sterile laboratory conditions using an appropriate liquid vector, such as bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride solution. When adding solvent to the peptide vial, direct the liquid stream against the inner glass wall rather than directly onto the lyophilized plug to prevent sheer stress damage to delicate peptide chains.
Gently swirl or invert the vial until complete dissolution is achieved; never vortex or vigorously agitate peptide solutions. Once reconstituted, aqueous peptide solutions are subject to degradation over time and must be refrigerated at 2°C to 8°C. For long-term storage of reconstituted aliquots, solutions should be frozen at -80°C to prevent repeated freeze-thaw cycles that break peptide bonds.
The supply chain integrity of research chemicals directly impacts institutional reproducibility. PX1 Research manufactures all research compounds within state-of-the-art facilities located across California and Arizona, USA. Operating under strict ISO 17025 and GMP-compliant frameworks, our production line avoids the purity degradation and cross-contamination frequently associated with unverified overseas sourcing.
Every production lot is assigned a unique batch number, enabling complete forward and backward supply chain traceability. Research institutions purchasing through PX1 receive lot-specific Certificates of Analysis (COAs) generated by independent, accredited third-party analytical laboratories. Access to raw HPLC chromatograms and mass spectra provides full transparency, ensuring your laboratory receives verified materials for critical research protocols.
PX1 Research caters to academic institutions, private biotechnology laboratories, and contract research organizations (CROs) requiring reliable, continuous supplies of high-purity peptides. For high-throughput screening or multi-phase longitudinal studies, institutional buyers can utilize our wholesale program to secure standardized lot quantities.
Bulk procurement guarantees lot uniformity across extended experimental timelines, eliminating inter-batch variance in cell assays. Orders placed Monday through Friday ship same-day from our dual facility hubs in California and Arizona, providing rapid delivery to minimize research project downtime.
What is the purity standard for PX1 Research Tesamorelin and Ipamorelin?
All Tesamorelin and Ipamorelin lots supplied by PX1 Research undergo RP-HPLC and mass spectrometry testing, verifying a minimum peptide purity of 99.0% with complete sequence verification.
Are Certificates of Analysis (COAs) available for each lot?
Yes. Every batch of peptide is issued a lot-specific COA generated by an independent, ISO 17025 accredited laboratory, containing raw HPLC chromatograms, mass spec analysis, and endotoxin levels.
What are the endotoxin limits for these research compounds?
PX1 Research enforces strict endotoxin safety thresholds, guaranteeing levels below 0.5 EU/mg verified via LAL assay testing to prevent inflammatory interference in cell assays.
How should lyophilized Tesamorelin and Ipamorelin be stored upon arrival?
Unreconstituted lyophilized vials should be stored at -20°C in a dry, dark environment. Under these conditions, the compounds remain stable for up to 24 months.
How should reconstituted solutions be handled in the lab?
After sterile reconstitution with bacteriostatic water, store the liquid solution at 2°C to 8°C. Avoid repeated freeze-thaw cycles and do not vortex the solution.
Why combine a GHRH analog with a GHSR-1a agonist in preclinical research?
Preclinical models evaluate Tesamorelin (GHRHR agonist) and Ipamorelin (GHSR-1a agonist) together to study intracellular cross-talk between cAMP/PKA and IP3/calcium signaling pathways in somatotrope cells.
Does Ipamorelin increase cortisol or prolactin in research models?
In vitro and animal study data demonstrate that Ipamorelin is highly selective for the GHSR-1a receptor, exhibiting negligible stimulation of ACTH, cortisol, or prolactin secretion.
Can these compounds be purchased for human consumption?
No. All products supplied by PX1 Research are strictly intended for laboratory research, analytical testing, and preclinical in vitro or in vivo experimentation. They are strictly not for human or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.